A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer ...

Pancreatic tumors reprogram immune cells that normally shut down tumor-killing cells, according to a team at Oregon Health & ...

After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – ...

A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...

As colorectal cancer rates rise among young people, most patients with advanced disease still only have one treatment option: ...

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of ...

While immunotherapy is the primary driver of skin sensitivity in melanoma care, Wong issued a "public service announcement" ...

Dr. Premal Thaker reports IMNN-001 shows early survival benefit in ovarian cancer by activating immune response directly in ...

A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma.

Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...

Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in ...